Page last updated: 2024-08-23

ursodeoxycholic acid and Stomach Neoplasms

ursodeoxycholic acid has been researched along with Stomach Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's3 (30.00)2.80

Authors

AuthorsStudies
Ahn, HS; Ahn, S; An, JY; Choi, MG; Eom, BW; Hur, H; Hwang, SH; Jang, DK; Kwon, OK; Lee, HH; Lee, KH; Lee, SH; Lee, SI; Man Yoon, H; Park, DJ; Park, YS; Ryu, SY; Son, T; Song, KY; Yoo, MW1
Nakeeb, A; Pitt, HA1
Bai, Y; Huang, J; Huang, W; Lu, X; Shu, P; Wen, F1
Han, SI; Lim, SC1
Choi, JE; Duong, HQ; Han, SI; Kang, JH; Lee, TB; Lim, SC; Oh, SH1
Duong, HQ; Han, SI; Lim, SC; Parajuli, KR1
Rhee, DK; Ryu, HC; Thao, TD; Yoo, SH1
Anello, A; Bertolotti, A; Covotta, A; Covotta, L; Paoletti, M; Urbano, V1
Calgaro, M; Fracchia, M; Galatola, G; Pellegrino, S; Pera, A; Secreto, P; Taraglio, S1
Classen, M; Dikimli, A; Kurtz, WJ; Leuschner, U1

Trials

1 trial(s) available for ursodeoxycholic acid and Stomach Neoplasms

ArticleYear
Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
    JAMA surgery, 2020, 08-01, Volume: 155, Issue:8

    Topics: Aged; Double-Blind Method; Female; Gallstones; Gastrectomy; Humans; Male; Middle Aged; Postoperative Complications; Stomach Neoplasms; Treatment Outcome; Ursodeoxycholic Acid

2020

Other Studies

9 other study(ies) available for ursodeoxycholic acid and Stomach Neoplasms

ArticleYear
Prevention of Gallstone Formation After Gastrectomy.
    JAMA surgery, 2020, 08-01, Volume: 155, Issue:8

    Topics: Gallstones; Gastrectomy; Humans; Stomach Neoplasms; Ursodeoxycholic Acid

2020
Identification of hub genes and discovery of promising compounds in gastric cancer based on bioinformatics analysis.
    Biomarkers in medicine, 2020, Volume: 14, Issue:12

    Topics: Amiodarone; Cell Cycle Proteins; Clomipramine; Collagen Type I; Databases, Genetic; Datasets as Topic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Ki-67 Antigen; Levallorphan; Microtubule-Associated Proteins; Neoplasm Proteins; Osteopontin; Piroxicam; Polo-Like Kinase 1; Procaine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Resveratrol; Small Molecule Libraries; Stomach Neoplasms; Ursodeoxycholic Acid; Vorinostat

2020
Ursodeoxycholic acid effectively kills drug-resistant gastric cancer cells through induction of autophagic death.
    Oncology reports, 2015, Volume: 34, Issue:3

    Topics: Apoptosis; Autophagy; Autophagy-Related Protein 5; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; fas Receptor; Gene Expression Regulation, Neoplastic; Humans; Microtubule-Associated Proteins; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Stomach Neoplasms; Ursodeoxycholic Acid

2015
Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
    Carcinogenesis, 2011, Volume: 32, Issue:5

    Topics: Animals; Apoptosis; Blotting, Western; Cell Proliferation; Cholagogues and Choleretics; Humans; Membrane Microdomains; Mice; Mice, Inbred BALB C; Necrosis; Protein Kinase C-delta; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Stomach Neoplasms; Tumor Cells, Cultured; Ursodeoxycholic Acid

2011
Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells.
    Oncology reports, 2012, Volume: 28, Issue:4

    Topics: Apoptosis; Butadienes; Caspases; Cell Line, Tumor; Enzyme Activation; Flavonoids; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Membrane Microdomains; Nitriles; Phosphorylation; Protein Kinase Inhibitors; Receptors, TNF-Related Apoptosis-Inducing Ligand; Stomach Neoplasms; Ursodeoxycholic Acid

2012
Antibacterial and anti-atrophic effects of a highly soluble, acid stable UDCA formula in Helicobacter pylori-induced gastritis.
    Biochemical pharmacology, 2008, Jun-01, Volume: 75, Issue:11

    Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Apoptosis; Cell Line, Tumor; Dosage Forms; Free Radical Scavengers; Gastritis, Atrophic; Gene Expression Regulation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen Peroxide; Malate Dehydrogenase; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Neutrophils; Reactive Oxygen Species; RNA, Messenger; Stomach Neoplasms; Time Factors; Ursodeoxycholic Acid

2008
[Large cystic polyps of the stomach].
    Il Giornale di chirurgia, 1995, Volume: 16, Issue:3

    Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Folic Acid; Gastrointestinal Agents; Gastroscopy; Hematinics; Humans; Polyps; Stomach Neoplasms; Ursodeoxycholic Acid; Vitamin B 12

1995
Biliary bile acid composition in gastric cancer.
    International journal of clinical & laboratory research, 1999, Volume: 29, Issue:1

    Topics: Adenocarcinoma; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Deoxycholic Acid; Female; Humans; Male; Stomach Neoplasms; Ursodeoxycholic Acid

1999
Antral mucosal bile acids in two types of chronic atrophic gastritis.
    The Tokai journal of experimental and clinical medicine, 1988, Volume: 13, Issue:1

    Topics: Adult; Aged; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Deoxycholic Acid; Female; Gastric Mucosa; Gastritis; Gastritis, Atrophic; Humans; Intestines; Lithocholic Acid; Male; Metaplasia; Middle Aged; Pyloric Antrum; Stomach Neoplasms; Ursodeoxycholic Acid

1988